| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 97 |
| 1 | ADALIMUMAB | 88 |
| 2 | DENOSUMAB | 86 |
| 3 | METHOTREXATE SODIUM | 54 |
| 4 | METHOTREXATE | 46 |
| 5 | PREDNISONE | 45 |
| 6 | ACETAMINOPHEN | 44 |
| 7 | DEXAMETHASONE | 41 |
| 8 | DEXAMETHASONE 1.5 MG | 41 |
| 9 | IBUPROFEN | 41 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IPRATROPRIUM BROMIDE | 1 | 0.0714 |
| 1 | CROVALIMAB | 1 | 0.0083 |
| 2 | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | 1 | 0.0061 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 16 | 0.0058 |
| 4 | CASTOR OIL | 1 | 0.0052 |
| 5 | RIVASTIGMINE TARTRATE | 2 | 0.0043 |
| 6 | SODIUM HYPOCHLORITE | 1 | 0.0038 |
| 7 | ERGOTAMINE TARTRATE AND CAFFEINE | 1 | 0.0037 |
| 8 | CLEMASTINE FUMARATE | 4 | 0.0029 |
| 9 | PRUCALOPRIDE SUCCINATE | 1 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 140 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 102 |
| 2 | RANK Ligand Inhibitor [EPC] | 86 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 86 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 65 |
| 5 | Benzodiazepine [EPC] | 48 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 46 |
| 7 | Vitamin D [EPC] | 45 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 41 |
| 9 | Vitamin C [EPC] | 41 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 9 | 0.0015 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 4 | Calcitonin [EPC] | 3 | 0.0010 |
| 5 | Provitamin D2 Compound [EPC] | 28 | 0.0009 |
| 6 | Interleukin-17A Antagonist [EPC] | 26 | 0.0007 |
| 7 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 8 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 9 | RANK Ligand Inhibitor [EPC] | 86 | 0.0004 |